ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

Identifying patients with locally advanced head and neck carcinoma on high risk of recurrence after definitive concurrent radiochemotherapy is of key importance for the selection for consolidation therapy and for individualized treatment intensification. In this multicenter study we analyzed recurre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacogenomics J
Hlavní autoři: Guberina, Maja, Sak, Ali, Pöttgen, Christoph, Tinhofer-Keilholz, Ingeborg, Budach, Volker, Balermpas, Panagiotis, Von der Grün, Jens, Rödel, Claus Michael, Gkika, Eleni, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Belka, Claus, Pigorsch, Steffi, Combs, Stephani E., Mönnich, David, Zips, Daniel, De-Colle, Chiara, Welz, Stefan, Linge, Annett, Lohaus, Fabian, Baretton, Gustavo, Gauler, Thomas, Baumann, Michael, Krause, Mechthild, Schuler, Martin, Bankfalvi, Agnes, Höing, Benedikt, Lang, Stephan, Stuschke, Martin
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840506/
https://ncbi.nlm.nih.gov/pubmed/32546699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41397-020-0174-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky